Clinical Trial Update: A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea

View source ↗

Summary

A post-marketing surveillance study in South Korea to monitor safety and real-world outcomes of Beyfortus (nirsevimab) for respiratory syncytial virus infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• BEYFORTUS (Nirsevimab)

Snippet

Sponsor: Sanofi | Conditions: Respiratory Syncytial Virus | Status: RECRUITING